You are here: Home » Reuters » News
Business Standard

Wall Street edges higher as industrial stocks attempt recovery

Reuters 

By Sruthi Shankar

(Reuters) - Wall Street's main indexes edged higher on Thursday as industrial stocks gained following three days of losses due to fears of trade war between and the

The index was up 0.15 percent, helped by gains in and Shares of planemaker pared early losses to trade down 0.8 percent.

The markets found support from economic data that showed the number of Americans filing for unemployment benefits fell last week, pointing to strength in labor market.

A more than expected rise in U.S. import prices in February indicated a steady pick up in inflation.

At 10:09 a.m. ET, the rose 0.37 percent to 24,848.55. The gained 0.12 percent to 2,752.75 and the was down just 0.03 percent at 7,494.93.

The indexes fell on Wednesday after U.S. sought to impose tariffs up to $60 billion on Chinese imports, while pressing for a cut in China's trade surplus with the by $100 billion.

said history showed trade wars are in nobody's interests, but that would protect its legitimate rights if "something happens we don't want to see".

"The problem is this type of rhetoric creates uncertainties and cap the markets," said Peter Cardillo, at Financial in "We're probably going to continue to slip in and out of the minus column for most of the day, we might be able to have a mid-session with upward bias."

Trump's decision to impose tariffs on and aluminum imports as well as on solar panels and washing machines has already sparked threats of retaliation from some trade partners.

Shares in have shed 8.8 percent since March 1, when Trump announced his plans to impose tariffs.

The stock was down another 1 percent in morning trading.

Major industrial stocks have been under pressure from the protectionist policies, which are likely to firm up with Trump replacing proponent with to lead the

jumped nearly 3 percent on report that the Chinese was planning to list in

Shares of rose 5.8 percent after the discount retailer's quarterly same-store sales beat estimates, and those of gained 5 percent after the retailer reported smaller-than-expected drop in same-store sales.

rose 8.45 percent after the company's experimental drug to treat patients with a rare blood disorder met the main goal in a late-stage study.

Advancing issues outnumbered decliners on the NYSE by 1,459 to 1,030. On the Nasdaq, 1,238 issues rose and 1,113 fell.

(Reporting by in Bengaluru; Editing by Arun Koyyur)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, March 15 2018. 19:53 IST
RECOMMENDED FOR YOU